| Literature DB >> 22478739 |
Abstract
The inherent difficulty of sustaining the rate of growth in healthcare spending may make biologics a touchstone for government intervention. The author proposes a combined cost-management and care-delivery standard that could lessen that threat.Year: 2008 PMID： 22478739 PMCID： PMC2702180
Source DB: PubMed Journal: Biotechnol Healthc ISSN： 1554-169X